An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis Bronchiectasis
NCT05344508
·
clinicaltrials.gov ↗
APPROVED_FOR_MARKETING
Status
INDUSTRY
Sponsor class
Conditions
Non-Cystic Fibrosis Bronchiectasis
Interventions
DRUG:
Brensocatib
Sponsor
Insmed Incorporated